Physician profile
Michael J Murphy
NPI 1265467393
$855.77
in general payments reported to CMS, 2019-2025
20 companies · $33.34 in 2025
The $33.34 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $63.62 · 2021: $53.72 · 2022: $110 · 2023: $166 · 2024: $18.15 · 2025: $33.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $158.29 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.89 | 2022-2023 | |
| Janssen Biotech, INC. | $65.29 | 2019-2023 | Erleada |
| Abbvie INC. | $59.68 | 2019-2022 | |
| Medtronic USA, INC. | $57.18 | 2019 | |
| Coloplast Corp | $53.74 | 2019-2022 | |
| Heron Therapeutics, INC. | $53.00 | 2019 | |
| Allergan, INC. | $47.13 | 2019-2020 | |
| Astellas Pharma US INC | $37.30 | 2023 | Xtandi |
| Pfizer INC. | $35.80 | 2019-2020 | |
| Olympus America INC. | $33.34 | 2025 | Itind System |
| Sumitomo Pharma America, INC. | $26.41 | 2023 | Orgovyx |
| Endo Pharmaceuticals INC. | $25.94 | 2019 | |
| Ferring Pharmaceuticals INC. | $22.58 | 2019 | |
| Blue Earth Diagnostics | $21.24 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.26 | 2023 | |
| Sun Pharmaceutical Industries INC. | $18.15 | 2024 | |
| Merck Sharp & Dohme LLC | $13.71 | 2020 | |
| Axonics, INC. | $13.55 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.